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Abstract
Methyllysine post-translational modifications (PTMs) of histones create binding sites for 
evolutionarily conserved reader domains that link nuclear host proteins and chromatin-modifying 
complexes to specific genomic regions. In the context of these events, adjacent histone PTMs are 
capable of altering the binding activity of readers toward their target marks. This provides a 
mechanism of “combinatorial readout” of PTMs that can enhance, decrease, or eliminate the 
association of readers with chromatin. In this Perspective, we focus on recent studies describing 
the impact of dynamic phospho-serine/threonine/tyrosine marks on the interaction of methyllysine 
readers with histones, summarize mechanistic aspects of the phospho/methyl readout, and 
highlight the significance of crosstalk between these PTMs. We also demonstrate that in addition 
to inhibiting binding and serving as a true switch, promoting dissociation of the methyllysine 
readers from chromatin, the phospho/methyl combination can act together in a cooperative manner
—thus adding a new layer of regulatory information that can be encoded in these dual histone 
PTMs.
Graphical Abstract
The nucleosome is a basic building block of chromatin that facilitates the compaction and 
stabilization of eukaryotic DNA. Structural and functional alterations in nucleosome 
organization provide the ability to control fundamental DNA-mediated nuclear processes, 
including gene transcription and DNA replication, recombination, and repair. Over 500 
PTMs or epigenetic marks have been identified in the nucleosomal histone proteins.1 A 
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number of these modifications have been shown to modulate chromatin activities through 
altering DNA–protein and protein–protein interactions.
Methylation of lysine residues represents one of the primary and frequently occurring 
histone PTMs. Recent mass spectrometry-based proteomic analysis uncovered 82 
methylation sites in the four core histones (H2A, H2B, H3, and H4) and the linker histone 
H1.1 Although the precise role for the majority of these marks is yet to be elucidated, several 
methyllysine PTMs have been studied extensively and their functions established to some 
degree.2,3 The canonical methyllysine PTMs include mono-, di-, and trimethylated K4, K9, 
K27, K36, and K79 of histone H3, as well as K20 of histone H4 and K26 of histone H1. 
These PTMs are implicated in mediating a wide range of biological processes, particularly 
transcription and DNA damage response. The trimethylated species, H3K4me3, is found 
around transcription start sites and is a hallmark of gene expression.4 Actively transcribed 
gene bodies are characterized by high levels of H3K36me3.3 In contrast, H3K27me3 
strongly associates with transcriptional repression, and H3K9me3 is enriched in condensed 
pericentric heterochromatic regions. H4K20me2, which is present in >80% of nucleosomes 
in mammalian cells, plays an important role in DNA damage repair.5,6
A set of domains, found in nuclear proteins and broadly named histone readers or epigenetic 
readers, bind methyllysine PTMs with a remarkably similar low-micromolar affinity (Kd ~ 
1–50 μM) although with a variable degree of specificity.7–10 Currently, 16 methyllysine 
readers have been identified and structurally and functionally characterized. Recognition of 
methyllysine PTMs by readers recruits proteins, often enzymes and components of 
multisubunit complexes, to particular genomic regions. This, in turn, initiates and/or 
propagates nuclear signals that are translated into specific biological outcomes. In many 
cases, the biological outcome depends on a combinatorial readout of multiple PTMs by 
spatially linked readers and on crosstalk between PTMs.7 The readout and crosstalk can be 
cooperative, antagonistic, or independent in nature.
The concept of interplay between histone PTMs that can influence the ability of 
methyllysine readers to associate with chromatin was first introduced by Fischle et al. in 
2003.11,12 The authors proposed that phosphorylation of a serine or threonine residue 
adjacent to a site of histone methylation could disrupt binding of a reader to this methylation 
site. The idea of binary “phospho/methyl” switching markedly expanded the epigenetic field 
and illuminated a possible mechanism for the release of readers from chromatin.11,13 This 
mechanism can be especially pertinent to the readers of stable marks with a low turnover 
rate, such as some methyllysine PTMs. Since the conception of the phospho/methyl switch 
hypothesis, a substantial body of work has been carried out in support of it. Of 48 
phosphorylation sites identified in histones,1 many are located nearby or adjacent to lysine 
residues that can be methylated. The coexistence of PTMs, including H3T3phK4me, 
H3K9meS10ph, H3K27meS28ph, and H3S31phK36me, has been confirmed 
experimentally.14 The pervasiveness of histone lysines being juxtaposed to potential 
phosphorylation sites suggests that phospho/methyl switching might be a common feature of 
effector protein regulation.
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In this Perspective, we summarize recent findings on the impact of phosphorylation on 
binding of methyllysine readers and highlight the significance of interplay between the 
methyllysine and phospho-serine/threonine/tyrosine PTMs. We also demonstrate that, in 
addition to impeding binding and serving as a true switch, the phospho/methyl combination 
can act together in a cooperative manner (i.e., enhancing binding)—thereby expanding 
potential of the epigenetic language.
REGULATION OF H3K9ME READERS BY H3S10PH
The first example of the phospho/methyl switch was reported for the H3K9me3S10ph 
combination of PTMs.11,12 Several groups independently found that the chromodomain 
(CD) of heterochromatin protein 1 (HP1) associates with the H3K9me3 mark, recruiting 
HP1 to heterochromatic regions and mediating the formation and maintenance of 
heterochromatin.15–18 However, during mitosis, HP1 is released from heterochromatin as a 
result of phosphorylation of H3S10 by Aurora B-type kinases, even though the H3K9me3 
mark persists.11,13 Conversely, inhibiting Aurora B kinase activity and eliminating H3S10 
phosphorylation causes HP1 to remain attached to heterochromatin, which disrupts normal 
chromatin decondensation and chromosome segregation during mitosis.11,13 In further 
support of the antagonistic effect of H3S10ph, in vitro binding assays demonstrate a ~50–
100-fold decrease in affinity of chromodomains of three HP1 isoforms for the dually 
modified H3K9me3S10ph peptide as compared to the affinity of these CDs for H3K9me3 
peptide.11
A similar significant loss of binding activity has been observed for several other 
chromodomain-containing proteins. Incorporation of S10ph in the H3K9me3 peptide results 
in a 350-fold decrease in binding of CD of yeast chromodomain protein 1 (Chp1).19 
Structural analysis of the Chp1 CD bound to histone H3K9me3 peptide provides a possible 
explanation for the inhibitory role of S10 phosphorylation and the displacement of CD from 
H3K9me3S10ph (Figure 1a). In the complex, H3K9me3 adopts a β-strand conformation.19 
The trimethylated K9 inserts into a canonical aromatic cage consisting of three aromatic 
residues and an aspartic acid, whereas the adjacent S10 residue forms hydrogen bonds with 
Glu55 and Asn59 via its hydroxyl group. Phosphorylation of S10 not only eliminates the 
hydrogen bonds but also creates electrostatic repulsion between the negatively charged 
moieties (i.e., the phosphate group of H3S10ph and the carboxylic group of Glu55), as well 
as causes a steric clash with Glu55, Pro56, and Asn59.
Chromodomains of CDY and CDYL2, two members of the chromodomain Y chromosome 
(CDY) family of proteins, have been shown to be sensitive to the presence of H3S10ph.20 
Interaction of these CDs with histone H3K9me3S10ph peptide was ~76–100 fold weaker as 
compared to their interaction with H3K9me3 peptide. Phosphorylation of H3S10 abolishes 
binding of the CD- and BAH domain-containing plant protein CMT3 and the homologous 
protein, ZMET2, to H3K9me2.21 The structure of the ZMET2 CD-H3K9me2 complex 
reveals that the hydroxyl group of S10 is hydrogen bonded to the carboxylate of Glu477.21 
Phosphorylation of S10 would result in the loss of the hydrogen bond and introduce 
unfavorable electrostatic forces.
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Due to extensive intermolecular contacts, the ankyrin repeats of histone methyltransferases 
G9a and G9a-like protein (GLP) display high specificity for H3K9me2/1.22 The H3K9me2 
peptide binds between the fourth and fifth ankyrin repeats in GLP, with dimethylated K9 
occupying a four-aromatic residue-binding cage. The S10–G13 residues of the H3K9me2 
peptide are involved in multiple interactions that enhance affinity and specificity. The 
hydroxyl group of S10 forms a hydrogen bond with the carboxylate group of Glu870. 
Substitution of Glu870 with an arginine or inclusion of H3S10ph eliminates binding of the 
ankyrin repeats to the methylated histone peptide, implying that phospho/methyl switching 
may play a role in regulating activities of these methyltransferases.
The ATRX-DNMT3-DNMT3L (ADD) domain of the alpha thalassemia/mental retardation 
syndrome X-linked protein (ATRX) is an example of an H3K9me3 reader that is insensitive 
to phosphorylation of H3S10.23–25 The ADD domain of ATRX exhibits relatively similar 
binding affinities for the H3K9me3S10ph and H3K9me3 peptides (Kds = 0.19 μM and 0.11 
μM, respectively).23 As in the complex with H3K9me3 peptide, in the ATRX ADD-
H3K9me3S10ph complex, K9me3 is restrained through hydrophobic and cation–π contacts 
and nonconventional carbon–oxygen hydrogen bonds.23,24,26 Although the phosphorylated 
H3S10 residue is positioned away from the protein surface and does not make direct contact 
with the ATRX ADD domain, it is stabilized via a salt bridge with the guanidinium group of 
H3R8 (Figure 1b). The significance of this intrapeptide contact in the complex was 
substantiated by the observation that binding of the ATRX ADD domain to the mutated 
H3R8AK9me3S10ph peptide was nearly 30-fold weaker than binding of this domain to the 
H3K9me3S10ph peptide. In contrast, the phosphorylation marks H3T6ph and, to a lesser 
extent, H3T3ph disrupt the association of the ATRX ADD domain with histone H3.23
Another example of an H3S10ph-insensitive reader of H3K9me3 is the tandem tudor 
domain (TTD) of UHRF1,27 an E3 ubiquitin ligase required for the maintenance of DNA 
methylation. Studies show that both isolated TTD and combined TTD-PHD domains of 
UHRF1 bind H3K9me3 regardless of S10 being phosphorylated or not.27,28 The structure of 
the TTD-H3K9me3S10ph complex reveals that the H3S10ph residue is positioned outward 
from the TTD aromatic cage and displays a high degree of rotational freedom.27,28 These 
findings are in agreement with the observation that UHRF1 remains associated with highly 
phosphorylated mitotic chromatin.27
Similar to the ATRX ADD domain, the second plant homeodomain (PHD2) finger of 
chromodomain helicase DNA binding protein 4 (CHD4) prefers H3K9me3 to the 
unmodified histone H3 tail.29,30 However, the PHD2 finger does not tolerate 
phosphorylation of either T3, T6, or S10, as observed in an on-beads combinatorial H3 
peptide library assay.29 The solution structure of PHD2 in complex with H3K9me3 peptide 
shows that both T3 and T6 are involved in the interaction.30 The side chains of T3 and T6 
are positioned in shallow hydrophobic pockets, leaving insufficient space for the addition of 
phosphate groups to the hydroxyl moieties of these residues.30
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REGULATION OF H3K4ME3 READERS BY H3T3PH AND H3T6PH
Unlike the relatively stable H3K4me3 mark, H3T3ph and H3T6ph are transient PTMs that 
rise sharply during mitosis.31 The H3T3ph and H3T6ph marks are produced by the kinases 
Haspin and protein kinase CβI, respectively, and are found to be essential for proper 
condensation and segregation of chromosomes.32,33 Recent mass spectrometry and 
antibodies-based analyses confirmed the coexistence of H3T3ph and H3K4me3 on the same 
histone H3 tail.34
The double chromodomain (DCD) of the ATP-dependent chromatin-remodeling factor 
CHD1 binds tightly to the H3K4me3 mark.35 Phosphorylation of H3T3, adjacent to K4me3, 
results in a 25-fold decrease in binding. A structural comparison of the H3K4me3-bound 
and H3T3phK4me3-bound CHD1 DCD reveals that the free hydroxyl group of H3T3 forms 
a hydrogen bond with the backbone amide of H3Q5; however this intrapeptide bond is lost 
when H3T3 becomes phosphorylated (Figure 2a). More distal to K4me3 modifications, 
including H3S10ph, appear to have no effect on the interaction of the CHD1 DCD with 
H3K4me3.
Phosphorylation of H3T3 has a profound impact on binding of PHD fingers to H3K4me3 
and acts as a binary switch, abrogating the interaction in vitro and releasing the PHD finger-
containing proteins from H3K4me3-enriched chromatin in vivo. The inhibitory role of 
H3T3ph has been reported for the PHD fingers of death inducer obliterator 3 (DIDO3), 
inhibitor of growth 2 (ING2), mixed lineage leukemia 5 (MLL5), recombination activating 
gene 2 (RAG2), and transcription initiation factor TFIID subunit 3 (TAF3).36–39 The 
presence of H3T3ph reduces the TAF3 PHD finger affinity toward H3K4me3 by ~80-fold,37 
substantially compromises binding of MLL5 PHD,39 and completely eliminates binding of 
the DIDO3, ING2, and RAG2 PHD fingers.36,38 The effect of the H3T6ph mark varies, 
preventing binding of DIDO3 and RAG2 but leading to a modest ~10-fold decrease in 
binding of ING2.36,38
The crystal structure of the H3K4me3-bound PHD finger of DIDO3 shows an extensive 
binding site, with the first six residues of the peptide, including T3 and T6, making direct 
contacts with 16 residues of the PHD finger.38 The K4me3 residue of the peptide occupies a 
characteristic aromatic/hydrophobic cage, composed of Tyr270, His277, Met282, and 
Trp291 (Figure 2b). H3T3 is buried in a narrow cleft, flanked by Trp291 and Glu308. The 
hydroxyl group of T3 forms a hydrogen bond with Glu308, the side chain of which 
protrudes over T3, making it essentially solvent inaccessible. The hydroxyl group of T6 is 
hydrogen bonded to the backbone amide of Phe281 and the backbone carbonyl group of 
Asn279. The net of hydrogen bonding and hydrophobic interactions involving both T3 and 
T6 would likely be disrupted by phosphorylation of either threonine. Furthermore, addition 
of the negatively charged phosphate group to H3T3 is electrostatically unfavorable due to 
repulsion with the negatively charged side chain of Glu308. The interaction can also be 
precluded as a result of steric hindrance.
The TTD module of lysine-specific demethylase 4A (KDM4A) recognizes H3K4me3.40 
However, H3T3ph abolishes this interaction, and H3T6ph causes a 2-fold decrease in 
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affinity.36 The structure of the KDM4A TTD-H3K4me3 complex provides an explanation 
for the observed different effects of T3ph and T6ph.40 In the complex, T3 forms a hydrogen 
bond with the side chain of Asn940 and a water-mediated hydrogen bond with the 
carboxylate group of Asp939, whereas the only interaction observed between the hydroxyl 
group of T6 and the TTD is a water-mediated hydrogen bond with the carboxyl oxygen of 
Asp934. Therefore, phosphorylation of T6 may result in only a small decrease in binding.
EFFECTS OF H3.3S31PH AND H3Y41PH ON H3K36ME3 READERS
Two phosphorylation sites, H3.3S31ph and H3Y41ph, have been identified around the 
methylation site H3K36me3, suggesting that phosphorylation could modulate binding 
activities of the H3K36me3 specific readers. Phosphorylation of H3.3S31 is catalyzed by 
serine/threonine kinase CHK1 and occurs only in the histone variant H3.3 (the canonical 
histone H3.1 and H3.2 variants contain an alanine at this position) in late prometaphase and 
metaphase in mammalian cells.41,42 The protein tyrosine kinase JAK2 phosphorylates 
H3Y41, producing the H3Y41ph mark that excludes HP1α from chromatin.43 The H3Y41ph 
PTM is positioned near the DNA entrance/exit sites in the nucleosome and is found to 
increase nucleosome unwrapping and enhance DNA accessibility to transcription regulatory 
complexes.44
To determine the effect of H3.3S31ph and H3Y41ph, we synthesized the histone H3.3 
peptides, H3.3H36me3, H3.3S31phK36me3, and H3.3K36me3Y41ph (residues 27–45 of 
H3.3) and examined their interactions with the PHF1 Tudor domain and the BRPF1 PWWP 
domain—two previously identified readers of the H3K36me3 mark45,46 by NMR (Figure 3). 
Titration of the H3.3H36me3 peptide to the 15N-labeled PHF1 Tudor domain caused large 
chemical shift perturbations (CSPs) in the intermediate exchange regime on the NMR time 
scale, confirming tight binding (Kd = 37 μM, as calculated based on CSPs; Figure 3c and 
Table 1). The addition of the two phosphorylated peptides induced CSPs mostly similar in 
direction to CSPs observed upon the addition of the H3.3K36me3 peptide, inferring that the 
binding mode is conserved. However, an intermediate-to-fast exchange regime for the 
binding of H3.3S31phK36me3 and a fast exchange regime for the binding of 
H3.3K36me3Y41ph indicated that both phosphorylation marks impair the Tudor-
H3K36me3 interaction. The Kds calculated from the NMR experiments revealed a 7- and 
13-fold decrease in binding for the H3.3S31phK36me3 and H3.3K36me3Y41ph peptides, 
respectively (Table 1).
Surprisingly, titration of the phosphorylated peptides to the 15N-labeled PWWP domain of 
BRPF1 induced CSPs larger in magnitude than CSPs seen upon titration of 
unphosphorylated H3.3K36me3 peptide (Figure 3d). The Kd values were found to be 3.9 
mM, 2.3 mM, and 1.8 mM, for the interaction with H3.3H36me3, H3.3S31phK36me3, and 
H3.3K36me3Y41ph, respectively. These data imply that phosphorylation, particularly of 
H3Y41, enhances binding of the BRPF1 PWWP domain to the H3K36me3 PTM by ~2 fold.
The structure of the PHF1 Tudor in complex with the H3.3K36me3 peptide (residues 31–40 
of H3.3) shows a very acidic binding site, especially where S31 is bound.45 The electrostatic 
repulsion between the negatively charged surface of the protein and the negatively charged 
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S31ph of the peptide may contribute to the decreased binding of the Tudor domain. 
Furthermore, the side chain of S31 forms intrapeptide hydrogen bonds with backbone atoms 
of T32 and G34. Modeling the S31ph mark results in steric clashes with T32 and G34 and 
with the carboxylate group of Glu66. A shorter peptide used for crystallization of the Tudor-
H3.3K36me3 complex does not contain Y41, which prevents similar evaluation of the effect 
of Y41ph.
Unlike the negatively charged H3K36me3-binding site in the PHF1 Tudor domain, the 
H3K36me3-binding site in the BRPF1 PWWP domain contains many basic residues,46 
which would favor electrostatic contacts with the negatively charged S31ph and Y41ph. 
Furthermore, the side chains of both A31 and Y41 point away from the binding interface, 
and there is no apparent steric clash upon modeling in the S31ph and Y41ph marks, 
inferring that the addition of a bulky phosphate group is permissible. Together, these 
findings demonstrate that the effect of H3.3S31 and H3Y41 phosphorylation on binding 
activities of the H3K36me3-recognizing proteins varies and depends on a particular reader.
CONCLUDING REMARKS
A wide array of cellular events, including the regulation of gene transcription, chromatin 
compaction, and DNA damage response, require methylation of lysine residues in histones. 
Methyllysine PTMs serve as docking sites for various evolutionarily conserved reader 
domains that function to recruit chromatin-modifying complexes to specific sites within the 
genome. These complexes can further modify the structure and dynamics of chromatin and 
alter the DNA accessibility to downstream effectors. As some methyllysine PTMs appear to 
be stable and persist throughout mitosis, a mechanism must exist to dismiss the readers of 
these marks when the association with chromatin is no longer needed. One of the releasing 
mechanisms, which was initially proposed by Fischle et al.12 and since then has been 
supported by a wealth of observations, is based on the fact that highly dynamic phospho-
serine/threonine/tyrosine marks coexist with other PTMs during mitosis. Consequently, 
phosphorylation can serve as a functional “switch,” promoting dissociation of the 
methyllysine readers from chromatin. Accumulating evidence also suggests that 
phosphorylation PTMs can prevent demethylation of the methyllysine marks by blocking the 
recruitment of epigenetic erasers (enzymes that remove PTMs), thereby contributing to the 
maintenance of epigenetic memory. The accurate transmission of epigenetic information, 
including bookmarking PTMs responsible for reactivation of transcriptional and chromatin-
remodeling programs, from mother to daughter cells is required to maintain cellular 
identity.47,48 Thus, phospho-methyl switching may be a broad and fundamental mechanism 
used by the cell to preserve epigenetic information during cell division and transfer it 
faithfully to the next generation.
In addition to impeding binding and serving as a true binary switch, the phospho/methyl 
combination can act together in a cooperative manner, as shown herein. This finding is 
significant, because it illustrates the complexity of the histone code and suggests that the 
functional outcome associated with phospho/methyl switches is site and context dependent 
and varies for individual readers. Furthermore, it is expected that other adjacent PTMs such 
as lysine ubiquitination and acetylation may affect activities of these switches. We anticipate 
Andrews et al. Page 7













that a more complex rulebook is likely in play regarding how PTMs cross talk, fine-tuning 
the end biological result. Understanding the mechanistic underpinnings of this rulebook and 
how it contributes to genome function will be a target of future research. Finally, as 
misregulation of the epigenetic machinery is at the heart of various human disorders, it will 
be essential to determine whether disruption of specific phospho/methyl switches plays a 
role in disease development and progression.
MATERIALS AND METHODS
Peptide Synthesis
Peptides were synthesized by UNC peptide synthesis core.
DNA Cloning, Expression, and Protein Purification
The Tudor domain of human PHF1 (aa 14–87) was expressed and purified as described.45 
The BRPF1 PWWP domain (aa 1064–1214) was cloned in pCOOL expression vector from 
full-length cDNA. The 15N-labeled PWWP was expressed as GST fusion protein in 
BL21(DE3) RIL cells grown in minimal media supplemented with 15NH4Cl (Sigma). Cells 
were lysed by sonication in 100 mM Tris-HCl (pH 8), 150 mM NaCl, and 1% (v/v) Triton 
X. Cellular derby was removed by centrifugation at 20 000g, and the supernatant was 
incubated with glutathione agarose resin for 2 h at 4 °C. Resin was washed with 100 mL of 
100 mM Tris-HCl (pH 8) supplemented with 150 mM NaCl. The GST tag was removed by 
cleavage with Thrombin overnight, and the cleaved protein was concentrated into PBS at a 
pH of 6.8.
NMR Spectroscopy
NMR experiments were performed on a Varian INOVA 600 MHz spectrometer at the 
University of Colorado School of Medicine NMR Core facility. CSPs experiments were 
carried out at 298 K using a uniformly 15N-labeled PWWP domain of BRPF1 and Tudor 
domain of PHF1. 1H,15N heteronuclear single quantum coherence (HSQC) spectra were 
collected in the presence of increasing concentrations of either H3.3K36me3, 
H3.3S31pK36me3, or H3.3K36me3Y41p peptides in PBS buffer at a pH of 6.8. Kd values 
were estimated using the following equation:
where [L] is concentration of the peptide, [P] is concentration of the protein, Δδ is observed 
chemical shift change, and Δδmax is the difference in chemical shifts of the free and the 
ligand-bound protein.
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Analysis of the phospho/methyl binding interface for K9me3 readers. (a) The structure of 
Chp1 CD (gray) in complex with H3K9me3 peptide (yellow). Chp1 CD is shown in a 
surface model with residues forming the K9me3 aromatic cage and binding partners of S10 
depicted as sticks and labeled. Only the side chains are shown for clarity. (b) The structure 
of ATRX ADD (cobalt) in complex with the H3K9me3S10ph peptide (salmon). The ATRX 
ADD domain is represented as a surface model with residues forming the K9me3 aromatic 
cage shown as sticks. Red dashes represent hydrogen bonds. PDB ID codes: 3G7L and 
3W5A.
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Analysis of the phospho/methyl binding interface for K4me3 readers. (a) The structure of 
CHD1 DCD (orange) in complex with the H3K4me3 peptide (charcoal). CHD1 DCD is 
shown in a surface model with residues forming the K4me3 aromatic cage depicted as 
sticks. For clarity, only the side chains are shown. (b) The structure of the DIDO3 PHD 
finger (orange) in complex with the H3K4me3 peptide (white). The DIDO3 PHD finger is 
depicted as a surface model with residues involved in the stabilization of T3, K4me3, and T6 
shown as sticks. Red dashes represent hydrogen bonds. PDB ID codes: 2B2W and 4L7X.
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Phosphorylation of H3.3S31 and H3Y41. Phosphorylation affects binding of the H3K36me3 
readers. (a, b) The electrostatic surface potentials of PHF1 Tudor (PDB ID: 4HCZ) and 
BRPF PWWP (PDB ID: 2X4X) are shown with the histone peptide in green. Histone 
residues that are subject to phosphorylation are shown in closed or dotted circles. (c, d) 
From left to right: superimposed 1H, 15N-HSQC spectra of PHF1 Tudor (c) and BRPF 
PWWP (d) with the addition of H3.3K36me3, H3.3S31phK36me3, or H3.3K36me3Y41ph. 
The protein/peptide molar ratios are color coded accordingly.
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Table 1
Binding Affinities of the H3K36me3 Readersa
peptide PHF1 Tudor, Kd (μM) BRFP1 PWWP, Kd (mM)
H3.3K36me3 37 ± 1 3.9 ± 0.3
H3.3S31phK36me3 260 ± 40 2.3 ± 0.9
H3.3K36me3Y41ph 480 ± 50 1.8 ± 0.3
a
Values are means of at least three independent determinations ± standard error.
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